OverviewSuggest Edit

Genprex is a biopharmaceutical company developing molecular therapies for the treatment of cancer. Its lead product candidate is Oncoprex, an active anti-cancer agent that is in Phase II clinical trials for the treatment of non-small cell lung cancer (NSCLC). The Company's mission is to address the unmet medical needs of a growing population of cancer patients worldwide, through the development of a novel class of cancer drugs: immunogene therapy. ... Show more
TypePublic
Founded2009
HQAustin, US
Websitegenprex.com

Locations

Genprex is headquartered in
Austin, United States

Location Map

Latest Updates

Employees (est.) (Feb 2019)5(-37%)
Share Price (Feb 2019)$1.4 (+5%)

Key People/Management at Genprex

Rodney Varner

Rodney Varner

Executive Chairman & CEO
Ryan Confer

Ryan Confer

CFO
Elizabeth Han

Elizabeth Han

Corporate Counsel
Show more

Genprex Office Locations

Genprex has an office in Austin
Austin, US (HQ)
2000 100 Congress Ave
Show all (1)
Report incorrect company information

Genprex Financials and Metrics

Genprex Revenue

USD

Net income (Q2, 2018)

(6.8m)

EBIT (Q2, 2018)

(6.7m)

Market capitalization (12-Feb-2019)

21.7m

Closing stock price (12-Feb-2019)

1.4

Cash (30-Jun-2018)

12.0m
Genprex's current market capitalization is $21.7 m.
Annual
USDFY, 2015FY, 2016FY, 2017

General and administrative expense

865.7k3.8m3.0m

R&D expense

202.0k354.9k289.9k

Operating expense total

1.1m4.1m3.3m

Depreciation and amortization

2.1k862.03.2k
Quarterly
USDQ3, 2016Q3, 2017Q1, 2018Q2, 2018

General and administrative expense

629.7k658.8k634.1k6.6m

R&D expense

89.9k55.5k51.6k164.6k

Operating expense total

719.6k715.1k686.6k6.7m

Depreciation and amortization

216.0808.0947.02.1k
Annual
USDFY, 2015FY, 2016FY, 2017

Cash

234.2k1.6m161.3k

Accounts Receivable

8.8k

Prepaid Expenses

15.8k36.5k

Current Assets

250.1k1.6m193.6k
Quarterly
USDQ2, 2017Q3, 2017Q1, 2018Q2, 2018

Cash

467.9k373.9k24.5k12.0m

Accounts Receivable

838.0

Prepaid Expenses

28.4k26.8k

Current Assets

496.3k400.8k58.4k12.5m
Annual
USDFY, 2015FY, 2016FY, 2017

Net Income

(1.1m)(4.1m)(3.3m)

Depreciation and Amortization

2.1k862.03.2k

Accounts Payable

(59.5k)269.3k545.3k

Cash From Operating Activities

(688.3k)(1.2m)(2.2m)
Quarterly
USDQ2, 2016Q3, 2016Q2, 2017Q3, 2017

Net Income

(2.4m)(3.1m)(1.9m)(2.6m)

Depreciation and Amortization

432.0648.01.4k2.2k

Accounts Payable

62.3k428.5k(75.7k)109.6k

Cash From Operating Activities

(249.6k)(399.6k)(1.3m)(2.0m)
USDY, 2018

Financial Leverage

1 x
Show all financial metrics

Genprex Operating Metrics

Feb, 2014Q2, 2017

Patent Applications

2

Patents Issued

30

Phase I Patients Enrolled

57 28
Show all operating metrics
Report incorrect company information

Genprex Online and Social Media Presence

Embed Graph
Report incorrect company information

Genprex Company Life and Culture

Report incorrect company information

Genprex Frequently Asked Questions

  • When was Genprex founded?

    Genprex was founded in 2009.

  • Who are Genprex key executives?

    Genprex's key executives are Rodney Varner, Ryan Confer and Elizabeth Han.

  • How many employees does Genprex have?

    Genprex has 5 employees.

  • Who are Genprex competitors?

    Competitors of Genprex include Biogen, MyoKardia and Athersys.

  • Where is Genprex headquarters?

    Genprex headquarters is located at 2000 100 Congress Ave, Austin.

  • Where are Genprex offices?

    Genprex has an office in Austin.

  • How many offices does Genprex have?

    Genprex has 1 office.